{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52028311",
    "licUnit": "1",
    "validDate": "2027-06-21 00:00:00.000",
    "issueDate": "2022-06-21 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202831103",
    "prodNameC": "恩瑞比膠囊",
    "prodNameE": "Inrebic Capsule",
    "indicationsName": [
        "適用於未曾接受Janus激酶抑制劑(JAK inhibitor)治療或曾接受ruxolitinib治療，中度風險或高風險之骨髓纖維化(包括原發性骨髓纖維化、真性紅血球增多症後骨髓纖維化、或血小板增多症後骨髓纖維化)成人病人\r\n"
    ],
    "does": "1130",
    "packageUnit": [
        {
            "packageSpec": "8-1000顆",
            "packageUnit": "HE"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": "A",
    "mainCategory": "A",
    "drBaseId": "5630943D-0024-4CB2-8A2E-D93BBD348FC0",
    "subCategory": [
        "A01"
    ],
    "ingredientsDesc": [
        "Fedratinib dihydrochloride monohydrate"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "5G"
    ],
    "applicantName": "台灣必治妥施貴寶股份有限公司",
    "applicantAddr": "臺北市松山區健康路156號4樓、5樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2027-06-21",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "FEF3FFF5-E625-4570-8FA9-211CFCEBC8D0",
            "factoryCode": "1",
            "factoryName": "CELGENE INTERNATIONAL SARL",
            "factoryAddr": "ROUTE DE PERREUX 1 2017 BOUDRY SWITZERLAND",
            "factoryCompanyAddr": null,
            "countryCode": "CH",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FCH0247000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013004220",
            "ingredientsName": "Fedratinib dihydrochloride monohydrate",
            "ingredientsDesc": "Fedratinib dihydrochloride monohydrate",
            "concentDesc": "(equivalent to 100 MG fedratinib)",
            "concent": "117.3000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [
        {
            "applicantName": "台灣大昌華嘉股份有限公司",
            "certNo": "DHA05202831114",
            "approveDocNo": "1110722210",
            "authDate": "2022-08-29",
            "validDate": "2027-06-21"
        }
    ],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EJ02"
        }
    ],
    "licBaseId": "6C2AE8C3-2291-4E55-8F1E-3B210DF36600"
}